Daniel Boada

Daniel Boada is a director in BRG’s Washington, DC office. He has directed and conducted a range of analyses presented to state and federal courts, arbitration panels, and the Federal Trade Commission. His practice emphasizes disputes in the healthcare provider and health insurance industries, with clients including physician groups, hospitals, payors, and pharmaceuticals. Mr. Boada’s quantitative analyses in the healthcare sector include mathematical models for patient choice, cost-effective analysis, statistical learning for data imputation, assessment of antitrust impact, damage estimation, and detection of anomalous billing and coding practices.

Mr. Boada’s consulting experience also includes a range of competition disputes in industries including transportation, telecommunication, mining and metals, food, and energy.